Decreased Expression of microRNA-451 is Associated with Imatinib Mesylate Resistance in Chronic Myeloid Leukemia Patients

被引：0
|
作者：
Khalifa, Khaled [1 ]
Abbas, Omaima [2 ]
Abdlfattah, Raafat [3 ]
Alhassanin, Suzan [4 ]
Shehata, Amira [1 ]
Esawy, Sally [2 ]
机构：
[1] Menoufia Univ, Dept Clin Pathol, Fac Med, Shibin Al Kawm, Egypt
[2] Menoufia Univ, Natl Liver Inst, Dept Clin Pathol, Shibin Al Kawm, Egypt
[3] Cairo Univ, Natl Canc Inst, Dept Med Oncol, Cairo, Egypt
[4] Menoufia Univ, Dept Clin Oncol, Fac Med, Shibin Al Kawm, Egypt
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2019年 / 19卷
关键词：
imatinib mesylate; microRNA-451; real-time polymerase chain reaction; CML; chronic myelogenous leukemia;
D O I：
10.1016/j.clml.2019.07.240
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CML-165
引用
收藏
页码：S293 / S293
页数：1
相关论文
共 50 条
  • [1] Decreased expression of microRNA-214 contributes to imatinib mesylate resistance of chronic myeloid leukemia patients by upregulating ABCB1 gene expression
    Jin, Jing
    Yao, Jia
    Yue, Fang
    Jin, Zhaoying
    Li, Dan
    Wang, Shan
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2018, 16 (03) : 1693 - 1700
  • [2] Gene expression signatures associated with treatment and resistance to imatinib mesylate in chronic myeloid leukemia patients.
    Oehler, V
    Branford, S
    Pogosova-Agadjanyan, E
    Shah, N
    Sawyers, C
    Mao, M
    Linsley, P
    Hughes, T
    Radich, J
    BLOOD, 2005, 106 (11) : 131A - 131A
  • [3] MicroRNA-451 in chronic myeloid leukemia: miR-451-BCR-ABL regulatory loop?
    Lopotova, Tereza
    Zackova, Marketa
    Klamova, Hana
    Moravcova, Jana
    LEUKEMIA RESEARCH, 2011, 35 (07) : 974 - 977
  • [4] Imatinib mesylate noncompliance simulating chronic myeloid leukemia resistance
    Sandoval, C
    Giamelli, J
    Jayabose, S
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2003, 25 (06) : 507 - 508
  • [5] Imatinib Mesylate in Chronic Myeloid Leukemia
    Mishra, Pravas
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2007, 28 (01) : 5 - 6
  • [6] Alterations in Sialylation Patterns are Significantly Associated with Imatinib Mesylate Resistance in Chronic Myeloid Leukemia
    Patel, Kinjal D.
    De, Maitri
    Jethva, Disha D.
    Rathod, Bharati S.
    Patel, Prabhudas S.
    ARCHIVES OF MEDICAL RESEARCH, 2022, 53 (01) : 51 - 58
  • [7] t(5;6;12) associated with resistance to imatinib mesylate in chronic myeloid leukemia
    Dencic-Fekete, Marija
    Dordevic, Vesna
    Storlazzi, Clelia Tiziana
    Jankovic, Gradimir
    Bogdanovic, Andrija
    Jovanovic, Jelica
    Rocchi, Mariano
    Todoric-Zivanovic, Biljana
    Strnad, Milica
    Gotic, Mirjana
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2009, 89 (04) : 508 - 512
  • [8] t(5;6;12) associated with resistance to imatinib mesylate in chronic myeloid leukemia
    Marija Denčić-Fekete
    Vesna Đorđević
    Clelia Tiziana Storlazzi
    Gradimir Janković
    Andrija Bogdanović
    Jelica Jovanović
    Mariano Rocchi
    Biljana Todorić-Živanović
    Milica Strnad
    Mirjana Gotić
    International Journal of Hematology, 2009, 89 : 508 - 512
  • [9] Adherence and/or discontinuation of imatinib mesylate in patients with chronic myeloid leukemia
    Alves, Alexandra Rodrigues
    Lima, William Gustavo
    Nagai, Michelly Martins
    Vilela Rodrigues, Joao Paulo
    Ayres, Lorena Rocha
    BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2016, 52 (04) : 581 - 589
  • [10] Imatinib Mesylate in Newly Diagnosed Patients of Chronic Myeloid Leukemia
    Jacob, L. Abraham
    Bapsy, P. P.
    Babu, K. Govind
    Lokanatha
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2007, 28 (01) : 20 - 25
12345